>> Black Swan Analysis Blog

Black Swan Analysis Blog

Targeted Therapies – A Novel Oral KRAS (G12C) specific Inhibitor

On November 15, 2019, Tags News, Oncology, Medicine

The KRAS (Kirsten rat sarcoma 2 viral oncogene homolog) DNA sequence falls into the classification of genes which when subject to specific mutations, contributes to the cancerous nature of the...

Repatha Has List Price Slashed Ahead Of Schedule

On November 14, 2019, Tags Pricing Strategies, RxPriceIndex

What is Repatha?

World Diabetes Day

On November 13, 2019, Tags News, Epiomic Database, Population, Epidemiology

On the 14th of November, World Diabetes Day will be marking the birthday of Sir Frederick Banting, who along with Charles Best co-discovered insulin in 1922. In remembrance of this discovery, WHO...

Movember 2019: Grow, Move & Host

On November 06, 2019, Tags News, Epidemiology

Movember is an annual event, held throughout the month of November every year. The aim of the campaign is to raise awareness of men’s health issues such as prostate cancer, testicular cancer and...

New report reveals startling drug price hikes in US Pharmaceutical wholesale acquisition

On November 05, 2019, Tags News, Medicine

A recent report by the Office of Statewide Health Planning and Development (OSHPD) have recently published data revealing changes in pharmaceutical Wholesale Acquisition Costs (WAC) from 2017 to...

The Importance of Orphan Drugs

On November 01, 2019, Tags Oncology, Medicine

There are approximately 7,000 rare diseases worldwide (Rarediseases.info.nih.gov, 2019) ranging from genetic in-borne diseases such as Acute-Lymphoblastic Leukaemia (ALL), to infectious diseases...

Modulating toxicity in photodynamic treatment (PDT, light activated) and improving imaging quality of theranostic(a) compounds to diagnose and treat cancer.

On October 30, 2019, Tags News, Oncology

Over the past two decades an array of targeted therapies have begun to revolutionise cancer treatment, providing better clinical outcomes in tumour types which exhibit certain biomarkers In...

Vertex Cystic Fibrosis Drugs approved for NHS use after 3-year financial dispute

On October 29, 2019, Tags Gene Therapy, Medicine

On October the 24th 2019, the NHS reported a licensing agreement with Vertex Pharmaceutical’s range of Cystic Fibrosis (CF) treatments (NHS England, 2019). This comes after a series of failed...

Biogen update: A new push for a failed Alzheimer’s drug!

On October 28, 2019, Tags News, Epidemiology, Medicine

According to the WHO, the worldwide prevalence of people living with dementia amounts to approximately 50 million people, with approximately 60% living in low- or middle- income countries. In...

What are Epiomic™ Epidemiology series reports

On October 25, 2019,

 

New Call-to-action

Subscribe to Email Updates

New call-to-action
RX Brochure CTA Large

Recent Posts

Free Brochure Epiomic